搜尋
ATAI Life Sciences NV
ATAI添加自選
7.180USD
0.0000.00%
收盤 07-31 16:00（美東）報價延遲15分鐘
2.66B總市值
虧損本益比TTM
關於 ATAI Life Sciences NV 公司
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
ATAI Life Sciences NV簡介
公司代碼ATAI
公司名稱ATAI Life Sciences NV
上市日期Jun 18, 2021
CEORao (Srinivas G)
員工數量54
證券類型Ordinary Share
年結日Jun 18
公司地址Prof. J.H.Bavincklaan 7
城市AMSTELVEEN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Netherlands
郵編1183 AT
電話31207932536
網址https://www.atai.com/
公司代碼ATAI
上市日期Jun 18, 2021
CEORao (Srinivas G)
ATAI Life Sciences NV公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+45.68%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
-100.00%
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
Ms. Anne Johnson
Ms. Anne Johnson
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Gerd G. Kochendoerfer
Dr. Gerd G. Kochendoerfer
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kevin James Craig, M.D.
Dr. Kevin James Craig, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Scott N. Braunstein, M.D.
Dr. Scott N. Braunstein, M.D.
Independent Supervisory Director
Independent Supervisory Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+45.68%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
-100.00%
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
常見問題
ATAI Life Sciences NV的前五大股東是誰？
ATAI Life Sciences NV的前五大股東如下：Dr. Glenn Frank Short, Ph.D.
有多少機構持有ATAI Life Sciences NV(ATAI)的股份？
截至2026Q1，共有296家機構持有ATAI Life Sciences NV的股份，合計持有的股份價值約為73.07M，占公司總股份的19.93% 。與2025Q4相比，機構持股有所增加，增幅為23428346.00。